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MAMMARY tumours induced in rats by the oral administration of9,10-dimethyl-
1,2-benzanthracene (DMBA) can be made to regress when the hormonal status is
altered as, for example, by oophorectomy, hypophysectomy or androgen admini-
stration (Huggins Briziarelli and Sutton, 1959). The exact means by which all
ofthese forms ofhormonal interference act on the tumour are not yet fully under-
stood. In this paper we have compared the effects of oophorectomy and vary-
ing doses of two androgens, testosterone and 17, hydroxy-5a androstan-3-one
(dihydrotestosterone) on tumours of this type.
MATERIAL AND METHODS
Non-inbred female rats, from stock imported from Sprague-Dawley of
Madison, Wisconsin, and bred commercially in Great Britain, were used through-
out. They were maintained on diet G.R. 25 with water ad libitum. At 50 + 1
days they were given intragastrically a single dose of DMBA dissolved in 2 ml. of
corn oil. The majority were given 30 mg. of DMBA but in some cases a dose of
50 mg. was used.
Starting 4 weeks after the carcinogen was given the rats were examined twice
weekly for the presence of tumours. When these were large enough they were
measured with calipers in two directions, one in the long axis of the tumour and
the other at right angles to it; the mean of the two diameters was used as our
measure of tumour size.
When it was seen from the measurements that the tumours were growing
steadily, oophorectomy was carried out or androgen injections were given.
Androgens and other hormones were given subcutaneously dissolved in corn oil
for 6 days per week in daily doses as follows:
Testosterone 0 2mg. in 0-2 ml. oil
1 mg.f
5 mg. in 1 ml. oil
Dihydrotestosterone 0.2mg.
il ~Si 0-2 ml. oil
1 mg.J
Oestradiol-17,8 2 g. in 04 ml. oil
Progesterone 8 mg.J156 STRETTON YOUNG, ROSEMARY A. BAKER AND JANET E. HELFENSTEIN
Pieces of tumour removed at biopsy or autopsy were fixed in Bouin's fluid and
10 per cent neutral buffered formalin (4 per cent formaldehyde) and embedded in
paraffin. Sections were cut at 4,t anid stained with haematoxylini and eosin.
Two hundred and thirtv-two tumours from 189 rats were examined.
RESULTS
The effects of giving androgens resembled the effects of o6phorectonmy in that
each was followed by tumour regression and the accompanying histological
changes were similar to one another (Huggins et al., 1959; Young, Cowan anid
Sutherland, 1963). There was one important difference, however, between the
effects ofthe two forms oftreatment. Whereas oophorectomy caused a reductioni
in tumour size which could be detected within 2 days, the administration of
testosterone permitted tumour growth to continue for up to 8 days. The mean
growth curves of 42 tumours regressing after oophorectomy and 28 tumours
regressing after 1 mg. of testosterone per rat per day are compared in Fig. 1.
With increasing doses of testosterone the period of delay diminished slightly
but it was clear that even with a very large dose of 5 mg. testosterone per rat per
day, immediate regression such as was seen after oophorectcmy did Inot ofteni
occur. The period of delay was considerably less on dihydrotestosterone,
particularly at the higher dose level. Delay was not related to tumour size at the
start of treatment. The proportions of tumours undergoing regressioii were inot
significantly different with any of the treatments we employed, but it was our
impression that the number of tumours showing histological regressioin anid the
degree of histological regression was considerably less on 5 mg. testosteronie than
at the two smaller dose levels. These results are summarized in Table I.
TABLE I. Nunibers of Tumours Undergoing Regression
Number of
Number of regressing tumours tumours with
,---~'-------------~ (l delay before M1ean( delay
Treatmnenit 'Macroscopic Histological regression (days)
Oophorectomy 43/53 18/22 5/43 . 0 0- 2
0-2 mg. Testosterone 21/33 15/28 . 17/21 9 2 1.5
1 mg. Testosterone. 28/44 17/38 24/28 6-4 -7
5 mg. Testosterone. 18/29 5/22 16/18 5 6 i10
0 2 mg. Dihydrotestosterone 24/35 15/31 13/24 . 44 10
1 mg. Dihydrotestosterone 28/38 20/33 15/28 2 =6
Total androgen 119/179 72/152,/; 8//119
Delay in the start ofregression following androgen therapy cani be explained in
various ways. Possibly androgens do not act directly on the tumour but depress
the output of pituitary hormones which may, in turn, reduce the secretion of
ovarian steroids If this hypothesis is true it should be possible to reactivate
tumours which are regressing on testosterone by the further administration of
oestradiol-17t3 and progesterone in doses which have caused further tumour
growth following oophorectomy Rats on testosterone whose tumours were regress-
ing, weregivenoestradiol-17, andprogesterone, 2,ug and 8mg. respectively perday.
Forty-two of the 77 tumours in rats so treated increased in size and in about -a of
them we found histological signs which we associate with reactivation. TheANDROGEN EFFECT ON INDUCED MAMMARY RAT TUMOURS
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FIGT. 1. The mean growth curves of 42 tumours regressing after oophorectomy and
28 tumours regressing after 1 mg. of testosterone per rat per day.
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epithelium became higher with more prominent nucleoli and more numerous
mitotic figures. The numbers ofthese animals are shown in Table II.
TABLE II.-Numbers ofRegressing Tumour Showing Reactivation on 2 ,ug.
Oestradiol-17/ and 8 mg. Progesterone
Number of reactivated tumours
Treatment causing , -
regression Macroscopic Histological
Oophorectomy . . . 12/13 7/7
0 2 mg. Testosterone . . 7/21 7/14
1 mg. Testosterone. . . 3/7 2/4
5 mg. Testosterone. . 5/8 1/4
0 2 mg. Dihydrotestosterone . 14/20 9/18
1 mg. Dihydrotestosterone . 13/21 16/16
Total androgen . . . 42/77 35/56
DISCUSSION
Androgens might act on the tumour independently and directly or by compet-
ing with oestrogens for receptor sites. It has been shown (Wang, 1963) that the
hormone can be detected in tumours ofthis kind within as short a time as t hour
after a single injection oftestosterone. Ifits action were a direct and independent
one, it would be difficult to reconcile this very rapid uptake of testosterone with
the long period of delay which we have observed before the androgen begins to
take effect, and if the androgens act by competing with oestrogen for a receptor
site it is unlikely that the administration ofmore oestrogen would cause the further
tumour growth which we have observed. We conclude, therefore, that androgen
does not act directly on tumour cells.
One ofthe known actions ofandrogens is to cause a reduction in the secretion
ofgonadotrophins which in turn will lead to reduced output ofovarian oestrogens.
The long delay in the effect of androgens and our finding of tumour reactivation
by oestradiol-17,8 and progesterone is compatible with a two stage mechanism
such as this.
Oestrogen plus cortisone plus thyroxine fail to reactivate tumours which are
regressing after hypophysectomy (Sterental et al., 1963), thus implying that a
pituitary factor independent ofthe ovary, adrenal and thyroid is also required for
growth. If androgens inhibit the secretion of such a factor this would effectively
stop tumour growth whereas the subsequent giving of oestradiol-17,B would
increase the output ofmammotrophic hormone and thus permit tumour growth to
start again. The effect ofandrogen on mammotrophic output by the pituitary is
still unsettled however.
Our experimental findings ofdelay in the effect oftestosterone and reactivation
by oestradiol-17, and progesterone would support the hypothesis of indirect
action by gonadotrophin inhibition without throwing any light on the alternative
possibility of action by mammotrophic suppression.
It has been shown that androgens can be converted to oestrogens in vitro and
in vivo. Complete conversion of testosterone to oestrogen cannot have taken
place in our experiments for the tumour was not maintained on the androgen at
any of the dose levels we employed but our findings of less obvious and less
frequent histological regression after the highest dose oftestosterone might be due
to a partial conversion of this sort.ANDROGEN EFFECT ON INDUCED MAMMARY RAT TUMOURS 159
Dihydrotestosterone on the other hand cannot be converted to oestrogen
(Ofner et al., 1962) and this may account for the shorter period of delav before
this androgen takes effect on the tumour.
SUMMARY
Testosterone and dihydrotestosterone caused tumour regression in about half
the rats to which they were given. Compared with the effects of o6phorectomy,
a considerable delay was noted before the androgens began to take effect.
Histological evidence of regression was less obvious with higher than with lower
doses of testosterone. Tumours regressing after androgen treatment were
reactivated by suitable doses of oestradiol-17/? and progesterone. It is suggested
that androgens act on induced mammary tumours through the intermediary
of the pituitary.
We are indebted to Mr. J. Gilbert and Mr. S. Moseley for technical assistanice.
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